Verve's leading programs aim to deliver lifelong cardiovascular risk reduction with a single dose by targeting genes strongly linked to cardiovascular disease Lilly's established capabilities in ...

The European direct-to-consumer genetic testing market is expected to reach USD 3.78 billion by 2035, growing from an estimated USD ...

Lilavati Hospital have successfully saved the life of a 78-year-old woman suffering from a serious heart condition known as Mitral Ann ...